Literature DB >> 9073030

Positron emission tomography (PET) in Machado-Joseph disease.

T Taniwaki1, T Sakai, T Kobayashi, Y Kuwabara, M Otsuka, Y Ichiya, K Masuda, I Goto.   

Abstract

Positron emission tomography studies on the regional cerebral glucose metabolism (rCMRglc) and 18F-fluorodopa (18F-Dopa) uptake were performed in 3 patients with Machado-Joseph disease (MJD), a dominantly inherited degenerative disease in the cerebellum, brainstem and basal ganglia. The rCMRglc in MJD was found to be significantly decreased in the cerebellum, brainstem, striatum and whole cerebral cortex in comparison to that in normal subjects. These results of rCMRglc were different from those for dominantly inherited olivopontocerebellar atrophy (dOPCA) or cerebellar cortical degeneration (CCD), however they were similar to those for sporadic olivopontocerebellar atrophy (sOPCA) and multiple system atrophy (MSA). The 18F-Dopa uptake in MJD was found to be significantly decreased in the putamen and relatively spared in the caudate, which was different from that of MSA. In addition, these results indicate that MJD showed a dysfunction, not only in the regions with apparent pathological involvement such as cerebellum, brainstem and nigro-striatal dopaminergic system, but also in the cerebral cortex and the striatum where no pathology could be observed using conventional morphological techniques.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9073030     DOI: 10.1016/s0022-510x(96)00242-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease.

Authors:  B W Soong; R S Liu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

3.  Executive dysfunction in patients with spinocerebellar ataxia type 3.

Authors:  Itaru Tamura; Asako Takei; Shinsuke Hamada; Hiroyuki Soma; Michio Nonaka; Sanae Homma; Fumio Moriwaka
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

4.  Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3.

Authors:  Tátila Martins Lopes; Anelyssa D'Abreu; Marcondes Cavalcante França; Clarissa Lin Yasuda; Luiz Eduardo Betting; Adriana Bastos Samara; Gabriela Castellano; Júlio César Somazz; Marcio Luiz Figueredo Balthazar; Iscia Lopes-Cendes; Fernando Cendes
Journal:  J Neurol       Date:  2013-06-18       Impact factor: 4.849

5.  Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6 : a voxel-based FDG-positron emission tomography analysis.

Authors:  Po-Shan Wang; Ren-Shyan Liu; Bang-Hung Yang; Bing-Wen Soong
Journal:  J Neurol       Date:  2007-04-30       Impact factor: 4.849

Review 6.  Caring for Machado-Joseph disease: current understanding and how to help patients.

Authors:  Anelyssa D'Abreu; Marcondes C França; Henry L Paulson; Iscia Lopes-Cendes
Journal:  Parkinsonism Relat Disord       Date:  2009-10-06       Impact factor: 4.891

7.  RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease.

Authors:  Clévio Nóbrega; Isabel Nascimento-Ferreira; Isabel Onofre; David Albuquerque; Nicole Déglon; Luís Pereira de Almeida
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

8.  Rhes travels from cell to cell and transports Huntington disease protein via TNT-like protrusion.

Authors:  Manish Sharma; Srinivasa Subramaniam
Journal:  J Cell Biol       Date:  2019-05-10       Impact factor: 10.539

Review 9.  Mouse models of polyglutamine diseases: review and data table. Part I.

Authors:  Maciej Figiel; Wojciech J Szlachcic; Pawel M Switonski; Agnieszka Gabka; Wlodzimierz J Krzyzosiak
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

10.  Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models.

Authors:  Carlos A Matos; Clévio Nóbrega; Susana R Louros; Bruno Almeida; Elisabete Ferreiro; Jorge Valero; Luís Pereira de Almeida; Sandra Macedo-Ribeiro; Ana Luísa Carvalho
Journal:  J Cell Biol       Date:  2016-02-15       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.